Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Etoposide Injection

Approval Number

国药准字H35021393

Company福建南少林药业有限公司

Registration Date

November 19, 2019

Drug Information

Generic Name

依托泊苷注射液

Brand Name

海韦林

Dosage Form

注射剂

Strength

2ml:40mg

Drug Type

化学药品

Registration Date

November 19, 2019

Company Information

Applicant Company

Company Name福建南少林药业有限公司

Company Address

福清市融侨经济技术开发区

Manufacturing Company

Company Name福建南少林药业有限公司

Company Address

福建省福清市石竹街道福政路10号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

依托泊苷注射液 - NMPA 批准文号 | MedPath